A clinical research study to evaluate the added benefit of an investigational drug in people with moderate Alzheimer’s disease who are currently taking stable doses of Donepezil and either Memantine or Namenda XR.

  • STATUS
    Recruiting
  • sponsor
    Suven Life Sciences
Updated on 25 March 2021

Summary

A clinical research study to evaluate the added benefit of an investigational drug in people with moderate Alzheimer’s disease who are currently taking stable doses of Donepezil and either Memantine or Namenda XR.

Description

SPRI Clinical Trials of Brooklyn, under the sponsorship of Suven Life Sciences, is currently participating in the clinical evaluation of the safety and effectiveness of an investigational drug in persons with moderate dementia due to Alzheimer’s disease.

Study medication and all study-related exams, tests, and procedures will be provided at no cost to you or your insurance company, with the exception of Namenda XR® or NamzaricTM.

Details
Clinical Study IdentifierTX145342
SponsorSuven Life Sciences
Last Modified on25 March 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age between 50 yrs and 85 yrs?
Gender: Male or Female
At a minimum, to be eligible to participate in this clinical trial, you or someone you know must
be between the ages of 50 and 85 years of age
have been diagnosed at least 1 year prior to study inception with moderate Alzheimer’s disease
currently be on a stable dose of donepezil (10 mg) and Memantine (10 mg bid) or Namenda XR (28 mg qd), or Namzaric ™ for at least the past 3 months
have a friend, family member or caregiver who has frequent contact with the participant and is willing to accompany the participant to all study-related visits, oversee the participant’s compliance with taking the study medication and be able to inform on the participant’s overall cognitive and functional status
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note